Silence Therapeutics (SLN) Assets (2018 - 2025)
Silence Therapeutics' Assets history spans 8 years, with the latest figure at $131.4 million for Q4 2025.
- On a quarterly basis, Assets fell 35.13% to $131.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $131.4 million, a 35.13% decrease, with the full-year FY2025 number at $131.4 million, down 35.13% from a year prior.
- Assets hit $131.4 million in Q4 2025 for Silence Therapeutics, down from $146.8 million in the prior quarter.
- Over the last five years, Assets for SLN hit a ceiling of $246.6 million in Q1 2024 and a floor of $105.0 million in Q2 2022.
- Historically, Assets has averaged $154.0 million across 5 years, with a median of $136.1 million in 2021.
- Biggest five-year swings in Assets: skyrocketed 115.03% in 2024 and later tumbled 35.13% in 2025.
- Tracing SLN's Assets over 5 years: stood at $129.7 million in 2021, then dropped by 2.76% to $126.1 million in 2022, then decreased by 7.65% to $116.4 million in 2023, then soared by 74.01% to $202.6 million in 2024, then tumbled by 35.13% to $131.4 million in 2025.
- Business Quant data shows Assets for SLN at $131.4 million in Q4 2025, $146.8 million in Q3 2025, and $165.2 million in Q2 2025.